View More View Less
  • 1 Sebészeti Klinika, Pécsi Tudományegyetem KK, 7643, Pécs, Ifjúság útja 13.
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $356.00

Absztrakt

A javuló eredmények ellenére a veseátültetés hosszú távú eredményei elmaradnak a benne rejlő potenciális lehetőségektől. A graftok késői elvesztésének legfőbb oka a cardiovascularis halálozás után, napjainkra a krónikus allograft-nephropathia lett. Ez egy olyan multietiológiás kórkép, melynek megjelenésére időben bármikor számíthatunk. Ha nem találunk időben megfelelő kezelési lehetőséget, akkor elkerülhetetlen az idült veseelégtelenség ismételt kialakulása. Tanulmányom célja annak vizsgálata, hogyan lehetne növelni az átültethető vesék számát, illetve javítani minőségüket.

  • 1. H Isoniemi J Ahonen B Eklund K Höckerstedt K Salmela E von Willebrand P Häyry 1990 Renal allograft immuno-suppression. I. Early inflammatory and rejection epi-sodes in triple drug treatment compared to double drug combinations or cyclosporin monotherapy Transpl Int 3 92 7.

    • Search Google Scholar
    • Export Citation
  • 2. JR Chapman PJ O'Connell BJ Nankivell 2005 Chronic renal allograft dysfunction J Am Soc Nephrol 16 3015 26.

  • 3. Kaló Z : A vesepótló kezelések és a vesetranszplantáció immunszupresszív terápiáinak gazdasági elemzése. Doktori értekezés. 2006.

    • Search Google Scholar
    • Export Citation
  • 4. F Dobbels L De Bleser S De Geest RN Fine 2007 Quality of life after kidney transplantation: the bright side of life? Adv Chronic Kidney Dis 14 370 8.

    • Search Google Scholar
    • Export Citation
  • 5. PJ Yates ML Nicholson 2006 The aetiology and pathogenesis of chronic allograft nephropathy Transpl Immunol 16 148 57.

  • 6. LC Racusen K Solez RB Colvin SM Bonsib MC Castro T Cavallo BP Croker AJ Demetris CB Drachenberg AB Fogo P Furness LW Gaber IW Gibson D Glotz JC Goldberg JD Grande PF Halloran HE Hansen B Hartley PJ Häyry CM Hill EO Hoffman LG Hunsicker AS Lindblad N Marcussen NJ Mihatsch T Nadasdy P Nickerson TS Olsen JC Papadimitriou PS Randhawa DC Rayner I Roberts S Rose D Rush L Salinas-Madrigal DR Salamon S Sund E Taskinen K Trpkov Y Yamaguchi 1999 The Banff 97 working classification of renal allograft pathology Kidney Int 55 713 23.

    • Search Google Scholar
    • Export Citation
  • 7. P Hayry T Paavonen E Taskinen E Tomlanovich T Mathew M Navarro E Ramos L Hooftman J Vamvakopoulos E Aavik S Yilmaz 2004 Protocol core needle biopsy and histological chronic allograft damage index as surrogate endpoint for long-term graft survival Transplant Proc 36 89 91.

    • Search Google Scholar
    • Export Citation
  • 8. V Audard M Matignon K Dahan P Lang P Grimbert 2008 Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview Transpl Int 21 11 7.

    • Search Google Scholar
    • Export Citation
  • 9. E Keitel T Michelon AF dos Santos AE Bittar JC Goldani P D'almeida Bianco RM Bruno A Losekann AA Messias D Bender JJ Bianchini V Duro Garcia 2004 Renal transplants using expanded cadaver donor criteria Ann Transplant 9 23 4.

    • Search Google Scholar
    • Export Citation
  • 10. JA Lopes F Moreso L Riera M Carrera M Ibernon X Fulladosa JM Grinyo D Seron 2005 Evaluation of pre-implantation kidney biopsies: comparison of Banff criteria to a morphometric approach Kidney Int 67 1595 600.

    • Search Google Scholar
    • Export Citation
  • 11. E Curschellas 1 Landmann M Dürig B Huser M Kyo V Basler G Thiel MJ Mihatsch 1995 Morphologic findings in “zero-hour” biopsies of renal transplants Clin Nephrol 5 215 22.

    • Search Google Scholar
    • Export Citation
  • 12. JM Campistol JM Grinyó 2001 Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity Transplantation 11 42 51.

    • Search Google Scholar
    • Export Citation
  • 13. E Dimény J Wahlberg E Larsson B Fellstrom 1995 Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection? Clin Transpl 2 79 84.

    • Search Google Scholar
    • Export Citation
  • 14. G Kootstra JH Daemen AP Oomen 1995 Categories of non-heart-beating donors Transplant Proc 5 2893 4.

  • 15. NR Brook ML Nicholson 2003 Kidney transplantation from non heart-beating donors Surgeon 6 311 22.

  • 16. http://www.tpm.org.

  • 17. F del Rio Gallegos JR Nunez Pena A Soria Garcia MA Moreno Roy A Varela J Calatayud 2004 Non heart beating donors. Succesfully expanding the donor's pool Ann Transplant 2 19 20.

    • Search Google Scholar
    • Export Citation
  • 18. AI Sanchez-Fructuoso M Marques D Prats J Conesa N Calvo MJ Perez-Contin J Blazquez C Fernandez E Corral F Del Rio JR Nunez A Barrientos 2006 Victims of cardiac arrest occurring outside the hospital: a source of transplantable kidneys Ann Intern Med 3 157 64.

    • Search Google Scholar
    • Export Citation
  • 19. J Chapman A Bock B Dussol L Fritsche V Kliem Y Lebranchu F Oppenheimer E Pohanka M Salvadori G Tufveson 2006 Follow-up after renal transplantation with organs from donors after cardiac death Transpl Int 9 715 9.

    • Search Google Scholar
    • Export Citation
  • 20. A Arimura 2007 PACAP: The road to discovery Peptides 28 1617 9.

  • 21. S Shioda H Ohtaki T Nakamachi K Dohi J Watanabe S Nakajo S Arata S Kitamura H Okuda F Takenoya Y Kitamura 2006 Pleiotropic functions of PACAP in the CNS. Neuroprotection and neurodevelopment Ann NY Acad Sci 1070 550 60.

    • Search Google Scholar
    • Export Citation
  • 22. M Hautmann UG Friis M Desch V Tondorov H Castrop F Segerer C Otto G Schütz F Schweda 2007 Pituitary adenylate cyclase activating polypeptide stimulates renin secretion via activation of PAC1 receptors J Am Soc Nephrol 18 1150 6.

    • Search Google Scholar
    • Export Citation
  • 23. A Somogyvári-Vígh D Reglődi 2004 Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide Review Curr Pharm Des 10 2861 89.

    • Search Google Scholar
    • Export Citation
  • 24. M Riera J Torras JM Cruzado N Loberas J Liron I Herrero MA Navarro JM Grinyo 2001 The enhancement of endogenous cAMP with pituitary adenylate cyclase activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response Transplantation 72 1217 23.

    • Search Google Scholar
    • Export Citation
  • 25. A Arimura M Li V Batuman 2006 Potential protective action of pituitary adenylate cyclase activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury Blood 107 661 8.

    • Search Google Scholar
    • Export Citation

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Aug 2020 1 0 0
Sep 2020 5 0 0
Oct 2020 0 0 0
Nov 2020 4 1 0
Dec 2020 3 0 0
Jan 2021 6 0 0
Feb 2021 0 0 0